Non-executive director

Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors

Retrieved on: 
Tuesday, September 12, 2023
Non-executive director, University, AIM, Honours degree, Health, Forster, MBA, Research, Sale, Triple accreditation, Development, Henley Business School, Committee, University of Pavia, Therapy, NYSE, UK, H5 (US company), Management, OSCHR, Protalix BioTherapeutics

Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.

Key Points: 
  • Zeev Bronfeld, the current Chairman of the Company's Board of Directors, will retire on the same day.
  • "We are very pleased that Eliot will be joining our Board of Directors," commented Dror Bashan, Protalix's President and Chief Executive Officer.
  • He will be a valuable contribution to our Board of Directors as we leverage our development successes to strengthen our research and development efforts."
  • "I am delighted and honored to join Protalix as Chairman of its Board of Directors, and very much look forward to working with Protalix's talented officers, directors and employees," said Dr. Forster.

The Paper Excellence Group Announces Renewed Business Unit Structure

Retrieved on: 
Friday, July 28, 2023
Heart, Weyerhaeuser, Senior, Georgia-Pacific, Wood, Pulp, Paper, Resolute Forest Products, International Paper, Growth, Non-executive director, Cryptocurrency, Management, Port Alberni, Domtar

RICHMOND, BC, July 28, 2023 /PRNewswire/ - The Paper Excellence Group (Paper Excellence) today announced its updated organizational structure for its business units following the recent acquisitions of Resolute Forest Products in March 2023 and Domtar in November 2021.

Key Points: 
  • RICHMOND, BC, July 28, 2023 /PRNewswire/ - The Paper Excellence Group (Paper Excellence) today announced its updated organizational structure for its business units following the recent acquisitions of Resolute Forest Products in March 2023 and Domtar in November 2021.
  • Steve Henry, currently Domtar's Executive Vice President and Chief Operating Officer, has been named President of the Paper & Packaging business unit with responsibility for all legacy Domtar pulp, paper and packaging operations as well as Paper Excellence Canada's Port Alberni and Crofton mills.
  • The leader of the Pulp & Tissue business unit consisting of all legacy Resolute pulp, paper and tissue operations as well as the non-integrated Paper Excellence Canada pulp mills will be announced at a later date.
  • Mr. Tremblay and Mr. Lafave will serve as co-leaders of the business unit until a permanent leader is named.

ViroCell Appoints Brian Collins as CFO

Retrieved on: 
Wednesday, July 26, 2023
Professional Services, Health, Genetics, Finance, Clinical Trials, Biotechnology, GMP, LSE, Risk, Oxford Biomedica, Gene, Great Ormond Street Hospital for Children NHS Foundation Trust, B2B, Avery Dennison, Organic, Doctor of Philosophy, OXB, CDMO, Cell, HR, H.B. Fuller, CFO, Growth, Great Ormond Street Hospital, Operational excellence, Non-executive director, Pharmaceutical industry, Management, Vaccine

ViroCell Biologics (“ViroCell” or the “Company”), a specialist Contract Development and Manufacturing Organisation (“CDMO”) in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer (“CFO”).

Key Points: 
  • ViroCell Biologics (“ViroCell” or the “Company”), a specialist Contract Development and Manufacturing Organisation (“CDMO”) in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer (“CFO”).
  • John W. Hadden II, CEO at ViroCell, commented, “I am delighted to welcome Brian to the ViroCell team.
  • Prior to the CGT Catapult, Brian was the CFO of Coveris Packaging and before that held numerous financial and operational roles of increasing seniority at companies, including MSX International, HB Fuller and Avery Dennison.
  • Throughout his 30-year career in finance, Brian has built finance operations, led acquisitions, and secured company financings.

Clear Channel Outdoor Holdings, Inc. Has Entered Into Exclusive Discussions to Sell its France Business

Retrieved on: 
Monday, July 17, 2023
Senior advisor, Frontenac Company, Investment, NYSE, SAN, CCO, Non-executive director, Security (finance), Management, Retail, Equinox

SAN ANTONIO, July 17, 2023 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the "Company") today announced that it has entered into exclusive discussions to sell its business in France to Equinox Industries ("Equinox"), a Paris-based industrial holding company that makes long-term majority equity investments.

Key Points: 
  • SAN ANTONIO, July 17, 2023 /PRNewswire/ -- Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) (the "Company") today announced that it has entered into exclusive discussions to sell its business in France to Equinox Industries ("Equinox"), a Paris-based industrial holding company that makes long-term majority equity investments.
  • In addition, Didier Quillot, a Senior Advisor to Equinox, would participate alongside Equinox in the proposed transaction and would be appointed Non-Executive Chairman of Clear Channel France upon completion.
  • The Company is not disclosing financial details of the contemplated transaction at this time, and investors should not assume any particular terms.
  • The Company has not set a timetable for completion of these processes and may suspend these processes at any time.

OLAPLEX Appoints Global Consumer Industry Veteran John P. Bilbrey to Board of Directors

Retrieved on: 
Tuesday, July 11, 2023
Partnership, Hershey, Elanco, Chairperson, Senior, JP, National Science Board, Campbell Soup Company, Bilbrey, Procter & Gamble, Kansas State University, Colgate-Palmolive, The Hershey Company, McCormick, Retirement, Chanel, McCormick & Company, Advent International, Professional Football Compensation Committee, Family, Compensated emancipation, Chair, Non-executive director, Management, Tapestry, Psychology

SANTA BARBARA, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced that it has appointed John P. "JP" Bilbrey to the Company’s Board of Directors (the “Board”).

Key Points: 
  • SANTA BARBARA, Calif., July 11, 2023 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) ("OLAPLEX" or the "Company"), today announced that it has appointed John P. "JP" Bilbrey to the Company’s Board of Directors (the “Board”).
  • A seasoned and accomplished executive within the global consumer space, Mr. Bilbrey will serve in the newly created role of Executive Chair of the Board.
  • “We’re thrilled to welcome JP to the Board and broader OLAPLEX family,” said JuE Wong, OLAPLEX’s President and Chief Executive Officer.
  • Mr. Bilbrey serves on the Board of Directors of Tapestry, Campbell Soup Company, Elanco Animal Health and Colgate-Palmolive, and previously served on the board of McCormick & Company.

Brookfield Reinsurance to Acquire AEL in $4.3 Billion Transaction

Retrieved on: 
Wednesday, July 5, 2023
BAM, Martha Plimpton, Insurance, LLP, BMO Capital Markets, Partnership, Cravath, Swaine & Moore, AEL, Securities and Exchange Commission (Nigeria), Oliver Cromwell, Form 8-K, Brookfield (corporation), VWAP, BN, NEWS, Hart–Scott–Rodino Antitrust Improvements Act, J. P. Morgan, Sullivan & Cromwell, TSX, Growth, NYSE, Barclays, DeBevoise, Non-executive director, Financial services, Security (finance), Reinsurance, Bank

BROOKFIELD, NEWS, July 05, 2023 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that they have entered into a definitive agreement whereby Brookfield Reinsurance will acquire all of the outstanding shares of common stock of AEL it does not already own in a cash and stock transaction that values AEL at approximately $4.3 billion.

Key Points: 
  • BROOKFIELD, NEWS, July 05, 2023 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that they have entered into a definitive agreement whereby Brookfield Reinsurance will acquire all of the outstanding shares of common stock of AEL it does not already own in a cash and stock transaction that values AEL at approximately $4.3 billion.
  • Brookfield Reinsurance intends to acquire from Brookfield Corporation (NYSE, TSX: BN) (“BN”) the BAM Shares required to satisfy the non-cash consideration offered to AEL shareholders.
  • Accordingly, there will be no net new issuance of shares of BAM, BN or Brookfield Reinsurance and no dilution to BAM, BN or Brookfield Reinsurance shareholders as a result of this transaction.
  • Barclays is serving as lead financial advisor to Brookfield Reinsurance and BMO Capital Markets is also acting as an advisor to Brookfield Reinsurance on this transaction.

Brookfield Reinsurance to Acquire AEL in $4.3 Billion Transaction

Retrieved on: 
Wednesday, July 5, 2023
Finance, Banking, Professional Services, Asset Management, Insurance, BAM, Martha Plimpton, LLP, BMO Capital Markets, Partnership, Cravath, Swaine & Moore, AEL, Securities and Exchange Commission (Nigeria), Oliver Cromwell, Brookfield (corporation), Form 8-K, VWAP, BN, Reinsurance, Hart–Scott–Rodino Antitrust Improvements Act, J. P. Morgan, Sullivan & Cromwell, TSX, Growth, NYSE, Barclays, DeBevoise, Non-executive director, Financial services, Security (finance), Bank

Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that they have entered into a definitive agreement whereby Brookfield Reinsurance will acquire all of the outstanding shares of common stock of AEL it does not already own in a cash and stock transaction that values AEL at approximately $4.3 billion.

Key Points: 
  • Brookfield Reinsurance (NYSE, TSX: BNRE) and American Equity Investment Life Holding Company (NYSE: AEL) (“AEL”) today announced that they have entered into a definitive agreement whereby Brookfield Reinsurance will acquire all of the outstanding shares of common stock of AEL it does not already own in a cash and stock transaction that values AEL at approximately $4.3 billion.
  • Anant Bhalla, President and Chief Executive Officer of AEL, said, “We are pleased to have reached this agreement with Brookfield Reinsurance and believe this transaction provides an excellent outcome for all AEL shareholders, policyholders and other stakeholders.
  • Brookfield Reinsurance intends to acquire from Brookfield Corporation (NYSE, TSX: BN) (“BN”) the BAM Shares required to satisfy the non-cash consideration offered to AEL shareholders.
  • Barclays is serving as lead financial advisor to Brookfield Reinsurance and BMO Capital Markets is also acting as an advisor to Brookfield Reinsurance on this transaction.

Cargo Demands Hold Steady at Port Houston

Retrieved on: 
Saturday, July 1, 2023
Maritime, Transport, Logistics, Supply Chain Management, Other Transport, Maintenance, Executive, Non-executive director, Engineer, Certificate, Multimedia, Corps, Federal, United States Environmental Protection Agency, Lancaster Port Commission, Bayport Terminal, United States Army Corps of Engineers, Safety, Management, Port Houston, Houston Ship Channel

The Port Commission of the Port of Houston Authority held its regular meeting on Tuesday, June 27.

Key Points: 
  • The Port Commission of the Port of Houston Authority held its regular meeting on Tuesday, June 27.
  • View the full release here: https://www.businesswire.com/news/home/20230630433710/en/
    Port Houston 2023 Community Grants Program recipients represent a significant investment in our local communities.
  • Guenther emphasized that Port Houston would work with its neighbors and Federal partners to continue to be responsive and would also explore future site uses.
  • During the meeting, Port Commissioner Clyde Fitzgerald also recognized the recent passing of former Port Commissioner Howard J. Middleton, Jr., who served Port Houston in that role for nearly two decades, from 1978-1996.

Immuron Chairman Transition

Retrieved on: 
Friday, June 30, 2023
Aston, Immuron, IMC, Smith & Nephew, CDI, GlobalData, Clostridioides, Food, Campylobacter, Food and Drug Administration, ASX, Infection, Clostridioides difficile, FDA, IND, Escherichia coli, Non-executive director, Pharmaceutical industry, Management

MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce the transition of Paul Brennan from Non-Executive Director to Chairman, effective July 1, 2023.

Key Points: 
  • MELBOURNE, Australia, June 30, 2023 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company, is pleased to announce the transition of Paul Brennan from Non-Executive Director to Chairman, effective July 1, 2023.
  • Dr Roger Aston will continue on the Board, transitioning from Chairman to Non-Executive Director.
  • Immuron is focusing on increasing penetration of existing products in existing markets while seeking to increase product offering, market geographies and sales channels to drive revenue growth and ultimately shareholder value.
  • CEO Steven Lydeamore said, “On behalf of the entire team at Immuron, I would like to acknowledge Roger’s significant contribution to the Company as Chairman over the past eleven years.

Vantage Risk Formalizes Board of Directors with New Appointments

Retrieved on: 
Tuesday, June 27, 2023
International Marxist Group, Insurance, Hellman & Friedman, Prudential Financial, Organization, Goldman Sachs, TIAA, Risk, Hellman, Non-executive director, Management, Financial adviser, Bill Lordan, Vantage

HAMILTON, Bermuda, June 27, 2023 /PRNewswire/ -- Vantage Group Holdings Ltd. (Vantage) has named two accomplished financial services executives as independent directors.

Key Points: 
  • HAMILTON, Bermuda, June 27, 2023 /PRNewswire/ -- Vantage Group Holdings Ltd. (Vantage) has named two accomplished financial services executives as independent directors.
  • Vantage Risk Formalizes Board of Directors with New Appointments Caroline Foulger and W. Dave Dowrich.
  • Caroline Foulger, a longtime advisor to insurance companies and financial institutions, and W. Dave Dowrich, Chief Financial Officer at TIAA, have joined the Vantage board.
  • "We are delighted to bring on Caroline and Dave as independent directors, and we welcome Jitij, Jim, and Adam to our board.